<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03966313</url>
  </required_header>
  <id_info>
    <org_study_id>7287</org_study_id>
    <nct_id>NCT03966313</nct_id>
  </id_info>
  <brief_title>Perioperative Modification of Hemostasis During Ventricular Assist Device Implantation</brief_title>
  <acronym>HemostVAD</acronym>
  <official_title>Perioperative Modification of Hemostasis During Ventricular Assist Device Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Implanting a ventricular assist device (VAD) is a promising therapy for end-stage cardiac
      failure. However, the implantation of these devices is associated with a high risk of severe
      hemorrhages and massive blood product transfusion in the first 48 hours following the
      implantation. The primary purpose of this study is to assess the functionality of the von
      Willebrand Factor (vWF) which is essential for hemostasis. The hypothesis is that the high
      shear stress generated by these VAD expose ADAMTS13 cleaving site on the vWF. This result in
      a loss of high molecular weight vWF and an acquired von Willebrand syndrome.

      The secondary purpose of the protocol is to assess platelet function after the implantation
      of VAD. Indeed, platelet function might be affected shortly after the implantation of the
      device.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 21, 2019</start_date>
  <completion_date type="Anticipated">June 21, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 21, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Von Willebrand Factor activity</measure>
    <time_frame>From Baseline to 48 hours</time_frame>
    <description>Change of Von Willebrand Factor from Baseline to 48 hours</description>
  </primary_outcome>
  <enrollment type="Anticipated">45</enrollment>
  <condition>End-stage Heart Failure</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ventricular assist device implantation</intervention_name>
    <description>Blood sampling in patients under surgery for ventricular assist device implantation at five time points:
After anesthetic induction
Before starting the device
2h, 6h and 48h after starting the device</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      -  Whole blood

        -  Plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with end-stage heart failure (acute or chronic) under surgery for implantation of a
        ventricular assist device.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18 years old

          -  Who gave his consent to the study

          -  With an end-stage heart-failure

          -  Under surgery for a ventricular assist device implantation

          -  Scheduled or in emergency

        Exclusion Criteria:

          -  Preoperative anemia less than 7 g/dL

          -  Subject under the protection of justice

          -  Subject under guardianship or curatorship

          -  Pregnancy

          -  Breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Charles TACQUARD</last_name>
    <phone>0369551608</phone>
    <phone_ext>+33</phone_ext>
    <email>charlesambroise.tacquard@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopitaux Universitaire de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric DEMONSANT</last_name>
      <phone>0388115415</phone>
      <phone_ext>+33</phone_ext>
      <email>dpidrci@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>May 17, 2019</study_first_submitted>
  <study_first_submitted_qc>May 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 29, 2019</study_first_posted>
  <last_update_submitted>April 21, 2020</last_update_submitted>
  <last_update_submitted_qc>April 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

